Probable delirium is a presenting symptom of COVID-19 in frail, older adults: a cohort study of 322 hospitalised and 535 community-based older adults.


Journal

Age and ageing
ISSN: 1468-2834
Titre abrégé: Age Ageing
Pays: England
ID NLM: 0375655

Informations de publication

Date de publication:
08 01 2021
Historique:
received: 28 05 2020
pubmed: 29 9 2020
medline: 20 1 2021
entrez: 28 9 2020
Statut: ppublish

Résumé

Frailty, increased vulnerability to physiological stressors, is associated with adverse outcomes. COVID-19 exhibits a more severe disease course in older, comorbid adults. Awareness of atypical presentations is critical to facilitate early identification. To assess how frailty affects presenting COVID-19 symptoms in older adults. Observational cohort study of hospitalised older patients and self-report data for community-based older adults. Admissions to St Thomas' Hospital, London with laboratory-confirmed COVID-19. Community-based data for older adults using the COVID Symptom Study mobile application. Hospital cohort: patients aged 65 and over (n = 322); unscheduled hospital admission between 1 March 2020 and 5 May 2020; COVID-19 confirmed by RT-PCR of nasopharyngeal swab. Community-based cohort: participants aged 65 and over enrolled in the COVID Symptom Study (n = 535); reported test-positive for COVID-19 from 24 March (application launch) to 8 May 2020. Multivariable logistic regression analysis performed on age-matched samples from hospital and community-based cohorts to ascertain association of frailty with symptoms of confirmed COVID-19. Hospital cohort: significantly higher prevalence of probable delirium in the frail sample, with no difference in fever or cough. Community-based cohort: significantly higher prevalence of possible delirium in frailer, older adults and fatigue and shortness of breath. This is the first study demonstrating higher prevalence of probable delirium as a COVID-19 symptom in older adults with frailty compared to other older adults. This emphasises need for systematic frailty assessment and screening for delirium in acutely ill older patients in hospital and community settings. Clinicians should suspect COVID-19 in frail adults with delirium.

Sections du résumé

BACKGROUND
Frailty, increased vulnerability to physiological stressors, is associated with adverse outcomes. COVID-19 exhibits a more severe disease course in older, comorbid adults. Awareness of atypical presentations is critical to facilitate early identification.
OBJECTIVE
To assess how frailty affects presenting COVID-19 symptoms in older adults.
DESIGN
Observational cohort study of hospitalised older patients and self-report data for community-based older adults.
SETTING
Admissions to St Thomas' Hospital, London with laboratory-confirmed COVID-19. Community-based data for older adults using the COVID Symptom Study mobile application.
SUBJECTS
Hospital cohort: patients aged 65 and over (n = 322); unscheduled hospital admission between 1 March 2020 and 5 May 2020; COVID-19 confirmed by RT-PCR of nasopharyngeal swab. Community-based cohort: participants aged 65 and over enrolled in the COVID Symptom Study (n = 535); reported test-positive for COVID-19 from 24 March (application launch) to 8 May 2020.
METHODS
Multivariable logistic regression analysis performed on age-matched samples from hospital and community-based cohorts to ascertain association of frailty with symptoms of confirmed COVID-19.
RESULTS
Hospital cohort: significantly higher prevalence of probable delirium in the frail sample, with no difference in fever or cough. Community-based cohort: significantly higher prevalence of possible delirium in frailer, older adults and fatigue and shortness of breath.
CONCLUSIONS
This is the first study demonstrating higher prevalence of probable delirium as a COVID-19 symptom in older adults with frailty compared to other older adults. This emphasises need for systematic frailty assessment and screening for delirium in acutely ill older patients in hospital and community settings. Clinicians should suspect COVID-19 in frail adults with delirium.

Identifiants

pubmed: 32986799
pii: 5912424
doi: 10.1093/ageing/afaa223
pmc: PMC7543251
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

40-48

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/M004422/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R023131/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/V005030/1
Pays : United Kingdom

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of the British Geriatrics Society. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Références

Lancet. 2013 Mar 2;381(9868):752-62
pubmed: 23395245
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
Age Ageing. 2020 Jul 1;49(4):523-524
pubmed: 32315386
BMC Infect Dis. 2020 Oct 20;20(1):783
pubmed: 33081710
Lancet Public Health. 2020 Aug;5(8):e444-e451
pubmed: 32619408
Arch Gerontol Geriatr. 2008 Jul-Aug;47(1):9-18
pubmed: 17723247
Nurs Times. 2001 Jan 25-31;97(4):41-4
pubmed: 11954131
Nature. 2020 Aug;584(7821):430-436
pubmed: 32640463
J Infect. 2020 Jun;80(6):e14-e18
pubmed: 32171866
Eur Respir J. 2020 May 7;55(5):
pubmed: 32269088
Age Ageing. 2020 Jul 1;49(4):497-498
pubmed: 32374367
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
CMAJ. 2005 Aug 30;173(5):489-95
pubmed: 16129869
Neth J Med. 2017 Jul;75(6):241-246
pubmed: 28741583
Eur Geriatr Med. 2020 Oct;11(5):851-855
pubmed: 32683576
JAMA. 2020 May 12;323(18):1775-1776
pubmed: 32203977
J Gerontol A Biol Sci Med Sci. 2001 Mar;56(3):M146-56
pubmed: 11253156
Ageing Res Rev. 2017 Jul;36:1-10
pubmed: 28223244
J Infect. 2020 Jun;80(6):639-645
pubmed: 32240670
Eur Respir J. 2020 May 14;55(5):
pubmed: 32217650
J Clin Med. 2020 Jul 04;9(7):
pubmed: 32635468
J Med Virol. 2020 Sep;92(9):1596-1602
pubmed: 32249943
MMWR Morb Mortal Wkly Rep. 2020 Mar 27;69(12):343-346
pubmed: 32214079
Exp Gerontol. 2018 May;105:4-9
pubmed: 29111233

Auteurs

Maria Beatrice Zazzara (MB)

Department of Twin Research and Genetic Epidemiology, King's College London, St Thomas' Hospital, London, SE1 7EH, UK.
Department of Gerontology, Neuroscience and Orthopedics, Sacred Heart Catholic University, Rome, Italy.

Rose S Penfold (RS)

Department of Twin Research and Genetic Epidemiology, King's College London, St Thomas' Hospital, London, SE1 7EH, UK.

Amy L Roberts (AL)

Department of Twin Research and Genetic Epidemiology, King's College London, St Thomas' Hospital, London, SE1 7EH, UK.

Karla A Lee (KA)

Department of Twin Research and Genetic Epidemiology, King's College London, St Thomas' Hospital, London, SE1 7EH, UK.

Hannah Dooley (H)

Department of Twin Research and Genetic Epidemiology, King's College London, St Thomas' Hospital, London, SE1 7EH, UK.

Carole H Sudre (CH)

School of Biomedical Engineering and Imaging Sciences, King's College London, SE17EH, London, UK.

Carly Welch (C)

Institute of Inflammation and Ageing, University of Birmingham, B15 2TT Birmingham, UK.

Ruth C E Bowyer (RCE)

Department of Twin Research and Genetic Epidemiology, King's College London, St Thomas' Hospital, London, SE1 7EH, UK.

Alessia Visconti (A)

Department of Twin Research and Genetic Epidemiology, King's College London, St Thomas' Hospital, London, SE1 7EH, UK.

Massimo Mangino (M)

Department of Twin Research and Genetic Epidemiology, King's College London, St Thomas' Hospital, London, SE1 7EH, UK.
NIHR Biomedical Research Centre at Guy's and St Thomas' Foundation Trust, Guy's and St Thomas' NHS Foundation Trust and King's College London, London SE1 9RT, UK.

Maxim B Freidin (MB)

Department of Twin Research and Genetic Epidemiology, King's College London, St Thomas' Hospital, London, SE1 7EH, UK.

Julia S El-Sayed Moustafa (JS)

Department of Twin Research and Genetic Epidemiology, King's College London, St Thomas' Hospital, London, SE1 7EH, UK.

Kerrin S Small (KS)

Department of Twin Research and Genetic Epidemiology, King's College London, St Thomas' Hospital, London, SE1 7EH, UK.

Benjamin Murray (B)

School of Biomedical Engineering and Imaging Sciences, King's College London, SE17EH, London, UK.

Marc Modat (M)

School of Biomedical Engineering and Imaging Sciences, King's College London, SE17EH, London, UK.

Mark S Graham (MS)

School of Biomedical Engineering and Imaging Sciences, King's College London, SE17EH, London, UK.

Jonathan Wolf (J)

Zoe Global Limited, London SE1 7RW, UK.

Sebastien Ourselin (S)

School of Biomedical Engineering and Imaging Sciences, King's College London, SE17EH, London, UK.

Finbarr C Martin (FC)

Population Health Sciences, King's College London, SE17EH London, UK.

Claire J Steves (CJ)

Department of Twin Research and Genetic Epidemiology, King's College London, St Thomas' Hospital, London, SE1 7EH, UK.

Mary Ni Lochlainn (MN)

Department of Twin Research and Genetic Epidemiology, King's College London, St Thomas' Hospital, London, SE1 7EH, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH